Vinva Investment Management LTD Dexcom Inc Transaction History

Vinva Investment Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $403,734 - $514,046	-3,660 Reduced 25.09%	10,928 $1.25 Billion
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $799,540 - $980,700	7,000 Added 92.25%	14,588 $2.02 Billion
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $219,222 - $360,560	-2,904 Reduced 27.68%	7,588 $942 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $203,015 - $325,376	-2,359 Reduced 18.36%	10,492 $1 Billion
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $261,492 - $304,528	2,325 Added 22.09%	12,851 $1.64 Billion
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $1.09 Million - $1.29 Million	10,526 New	10,526 $1.2 Billion

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Vinva Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Vinva Investment Management LTD with notifications on news.